Results 211 to 220 of about 486,983 (268)
A CD169+ macrophage‐targeted immunomodulator (G‐LNP@S‐D) is developed to co‐deliver a SHP2 inhibitor and STING agonist, thereby restoring phagocytic function, enhancing antigen presentation by CD169+ macrophages, and promoting T cell priming to eradicate lymphatic metastasis.
Xiayun Chen +9 more
wiley +1 more source
Tyrosine kinase inhibitors in Ewing's sarcoma: a systematic review. [PDF]
Assi A +9 more
europepmc +1 more source
Netrin‐1 expression is upregulated in hepatic stellate cells (HSCs) during metabolic dysfunction–associated steatohepatitis and injury‐mediated liver fibrosis. Secreted Netrin‐1 establishes an autocrine positive feedback loop by binding to UNC5B receptors on HSCs.
Jiahui Zhao +8 more
wiley +1 more source
Role of Tyrosine Kinase Inhibitors in Modulating Chondrocyte Activity and Cartilage Diseases. [PDF]
Hadid KA, Zaki MK, Alassaf FA, Abed MN.
europepmc +1 more source
This study shows that integrin receptor CD49a (Itga1 gene) is significantly upregulated in hyperactivated microglia and microglia‐specific knockdown of Itga1 rescues neuroinflammation and neurodegeneration in a chronic Parkinson's disease (PD) model by targeting PGAM5‐mediated mitochondrial dysfunction and NLRP3 activation. Targeted inhibition of CD49a
Huanpeng Lu +6 more
wiley +1 more source
Significance of the tyrosine kinase 2 gene in both type 1 and type 2 diabetes. [PDF]
Nagafuchi S +5 more
europepmc +1 more source
RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs.
Christopher M. Hovens +5 more
openalex +2 more sources

